| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.0M | $768.0K | $1.5M |
| YoY Revenue Growth % | +33.6% | -47.8% | — |
| Gross Profit | -$802.0K | -$785.0K | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$48.2M | -$49.7M | -$46.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$46.4M | -$49.3M | -$43.5M |
| EBITDA (Normalized) | -$48.0M | -$49.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$38.1M | -$32.5M | -$33.5M |
| Capital Expenditures (CapEx) | $303.0K | $622.0K | — |
| Free Cash Flow (FCF) | -$38.4M | -$33.1M | -$33.5M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $4.0M | $13.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $39.6M | $22.5M | — |